| 000 | 01668 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513121114.0 | ||
| 264 | 0 | _c19970703 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a0165-5728 | ||
| 024 | 7 |
_a10.1016/s0165-5728(97)00029-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGold, D P | |
| 245 | 0 | 0 |
_aResults of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. _h[electronic resource] |
| 260 |
_bJournal of neuroimmunology _cJun 1997 |
||
| 300 |
_a29-38 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell, alpha-beta _xanalysis |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _aSmith, R A | |
| 700 | 1 | _aGolding, A B | |
| 700 | 1 | _aMorgan, E E | |
| 700 | 1 | _aDafashy, T | |
| 700 | 1 | _aNelson, J | |
| 700 | 1 | _aSmith, L | |
| 700 | 1 | _aDiveley, J | |
| 700 | 1 | _aLaxer, J A | |
| 700 | 1 | _aRichieri, S P | |
| 700 | 1 | _aCarlo, D J | |
| 700 | 1 | _aBrostoff, S W | |
| 700 | 1 | _aWilson, D B | |
| 773 | 0 |
_tJournal of neuroimmunology _gvol. 76 _gno. 1-2 _gp. 29-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-5728(97)00029-5 _zAvailable from publisher's website |
| 999 |
_c9165593 _d9165593 |
||